Fujikura, T., Yasuda, H., Iwakura, T., Tsuji, T., & Anders, H. (2018). MDM2 inhibitor ameliorates cisplatin‐induced nephropathy via NFκΒ signal inhibition. Pharmacol Res Perspect.
Citación estilo ChicagoFujikura, Tomoyuki, Hideo Yasuda, Takamasa Iwakura, Takayuki Tsuji, and Hans‐J Anders. "MDM2 Inhibitor Ameliorates Cisplatin‐induced Nephropathy Via NFκΒ Signal Inhibition." Pharmacol Res Perspect 2018.
Cita MLAFujikura, Tomoyuki, et al. "MDM2 Inhibitor Ameliorates Cisplatin‐induced Nephropathy Via NFκΒ Signal Inhibition." Pharmacol Res Perspect 2018.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.